| Symbol | IMNN |
|---|---|
| Name | IMUNON, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 997 LENOX DRIVE,SUITE 100, LAWRENCEVILLE, New Jersey, 08648, United States |
| Telephone | +1 -609 896-9100 |
| Fax | — |
| — | |
| Website | https://www.imunon.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000749647 |
| Description | Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the bodys immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. Additional info from NASDAQ: |
Director Tardugno Michael H 🟢 acquired 4.6K shares of Imunon, Inc. (IMNN) at $1.82 Transaction Date: Jun 18, 2026 | Filing ID: 021484
Read moreDirector Lindborg Stacy 🟢 acquired 1.8K shares of Imunon, Inc. (IMNN) at $1.82 Transaction Date: Jun 18, 2026 | Filing ID: 021444
Read moreIMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification
Read moreNew Form S-8 - Imunon, Inc. <b>Filed:</b> 2026-06-17 <b>AccNo:</b> 0001493152-26-029086 <b>Size:</b> 384 KB
Read moreDirector Tardugno Michael H 🟢 acquired 4.1K shares of Imunon, Inc. (IMNN) at $2.06 Transaction Date: Jun 05, 2026 | Filing ID: 020037
Read moreDirector Lindborg Stacy 🟢 acquired 1.6K shares of Imunon, Inc. (IMNN) at $2.06 Transaction Date: Jun 05, 2026 | Filing ID: 019994
Read more(90% Positive) IMUNON, INC. (IMNN) Announces Enrollment Update for notes Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment
Read more